Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Reata Pharmaceuticals Inc...

    NASDAQ: RETA · Real-Time Price · USD
    172.36
    0.04 (0.02%)
    At close: Sep 25, 2023, 10:00 PM

    Reata Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 2.22M 11.49M
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 2.22M 11.49M
    Operating Income
    		 -270.15M -244.71M
    Interest Income
    		 5.99M 177K
    Pretax Income
    		 -311.93M -297.84M
    Net Income
    		 -311.9M -297.39M
    Selling & General & Admin
    		 109.28M 99M
    Research & Development
    		 169.84M 155.99M
    Other Expenses
    		 1.13M 1.2M
    Operating Expenses
    		 280.25M 256.2M
    Interest Expense
    		 41.77M 53.25M
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 280.25M 256.2M
    Income Tax Expense
    		 -25K -450K
    Shares Outstanding (Basic)
    		 36.32M 36.32M
    Shares Outstanding (Diluted)
    		 36.32M 36.32M
    EPS (Basic)
    		 -8.59 -8.19
    EPS (Diluted)
    		 -8.59 -8.19
    EBITDA
    		 -269.02M -243.5M
    EBIT
    		 -270.15M -244.59M
    Depreciation & Amortization
    		 1.13M 1.2M

    Add to Watchlist